ASTELLAS PHARMA UNSP.ADR (YPHA) — Free Cash Flow Generation Index
ASTELLAS PHARMA UNSP.ADR (YPHA) has a Free Cash Flow Generation Index of 0.71x as of March 2025. Free cash flow of €137.18 Billion represents 1% of operating cash flow (€194.51 Billion). Read debt load of ASTELLAS PHARMA UNSP.ADR for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
ASTELLAS PHARMA UNSP.ADR Free Cash Flow Generation Index (2022–2025)
Historical FCF Generation Index trend for ASTELLAS PHARMA UNSP.ADR across 4 annual periods. Explore YPHA capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for ASTELLAS PHARMA UNSP.ADR (2022–2025)
Year-by-year Free Cash Flow Generation Index for ASTELLAS PHARMA UNSP.ADR. For the full company profile including market capitalisation, see ASTELLAS PHARMA UNSP.ADR market capitalisation.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.71x | €137.18 Billion | €194.51 Billion | €57.33 Billion | ▲ +35.2% |
| 2024 | 0.52x | €89.98 Billion | €172.47 Billion | €82.50 Billion | ▼ -28.5% |
| 2023 | 0.73x | €239.23 Billion | €327.77 Billion | €88.54 Billion | ▲ +3.8% |
| 2022 | 0.70x | €181.00 Billion | €257.44 Billion | €76.45 Billion | — |